The above-described effects of combined brca2 and tp53 mutations on mitotic germ cells (spermatogonia) in zebrafish suggest the interesting possibility that concurrent mutations in BRCA2 and TP53 could synergistically promote proliferation and suppress differentiation, which has important implications in the context of cancer initiation. Here, TP53 is linked to cancer.